
NASDAQ:GMVD • KYG394621414
The current stock price of GMVD is 0.181 USD. Today GMVD is down by 0%. In the past month the price decreased by -46%. In the past year, price decreased by -98.57%.
ChartMill assigns a technical rating of 0 / 10 to GMVD. When comparing the yearly performance of all stocks, GMVD is a bad performer in the overall market: 98.66% of all stocks are doing better.
7 analysts have analysed GMVD and the average price target is 4.08 USD. This implies a price increase of 2154.14% is expected in the next year compared to the current price of 0.181.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| CVS | CVS HEALTH CORP | 11.12 | 102.176B | ||
| CI | THE CIGNA GROUP | 9.08 | 74.804B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 99.09 | 26.595B | ||
| LH | LABCORP HOLDINGS INC | 15.71 | 23.46B | ||
| DGX | QUEST DIAGNOSTICS INC | 19.82 | 23.178B | ||
| GH | GUARDANT HEALTH INC | N/A | 12.021B | ||
| DVA | DAVITA INC | 11.51 | 10.438B | ||
| BTSG | BRIGHTSPRING HEALTH SERVICES | 29.31 | 7.867B | ||
| CHE | CHEMED CORP | 17.49 | 5.841B | ||
| RDNT | RADNET INC | 91.23 | 5.617B | ||
| OPCH | OPTION CARE HEALTH INC | 16.36 | 4.881B | ||
| BLLN | BILLIONTOONE INC CL A | 289.42 | 3.805B | ||
| HIMS | HIMS & HERS HEALTH INC | 28.97 | 3.606B |
View all stocks in the Health Care Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
G Medical Innovations Holdings Ltd. operates as a mobile health and digital health company, which engages in the development and marketing clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for remote monitoring and telemedicine projects. The company is headquartered in George Town, Grand Cayman. The company went IPO on 2017-10-26. The firm is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. The company develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. The company also develops wireless vital signs monitoring systems.
G MEDICAL INNOVATION HOLDING
P.O. Box 10008, Willow House, Cricket Square
GEORGE TOWN GRAND CAYMAN KY
Employees: 0
G Medical Innovations Holdings Ltd. operates as a mobile health and digital health company, which engages in the development and marketing clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for remote monitoring and telemedicine projects. The company is headquartered in George Town, Grand Cayman. The company went IPO on 2017-10-26. The firm is focused on the development of mHealth and telemedicine solutions and monitoring service platforms. The company develops and markets clinical and consumer medical-grade health monitoring solutions and offers end-to-end support for e-health projects. Its product lines consist of its Prizma medical device, a clinical grade device that can transform any smartphone into a medical monitoring device enabling both healthcare providers and individuals to monitor, manage and share a wide range of vital signs and biometric indicators and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiography data continuously, including its QT Prolongation Syndrome Detection Capabilities Patch. Its monitoring services include the provision of independent diagnostic testing facilities and private monitoring services. The company also develops wireless vital signs monitoring systems.
The current stock price of GMVD is 0.181 USD.
GMVD does not pay a dividend.
GMVD has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
7 analysts have analysed GMVD and the average price target is 4.08 USD. This implies a price increase of 2154.14% is expected in the next year compared to the current price of 0.181.